Chu, J. I. Et Al. 2015. Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome. 57th Annual Meeting of the American-Society-of-Hematology , (Florida, United States Of America).

Chu, J. I., Henderson, L. A., Armant, M., Male, F., Dansereau, C. H., MacKinnon, B., ... Burke, C. J.(2015). Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome . 57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America

Chu, Julia Et Al. "Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome," 57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 2015

Chu, Julia I. Et Al. "Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome." 57th Annual Meeting of the American-Society-of-Hematology , Florida, United States Of America, 2015

Chu, J. I. Et Al. (2015) . "Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome." 57th Annual Meeting of the American-Society-of-Hematology , Florida, United States Of America.

@conferencepaper{conferencepaper, author={Julia I. Chu Et Al. }, title={Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome}, congress name={57th Annual Meeting of the American-Society-of-Hematology}, city={Florida}, country={United States Of America}, year={2015}}